If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback